Genesys International Corporation has unveiled its 2026 ESOP scheme covering 30 lakh options and confirmed the appointment of G. K. Choksi & Co. as statutory auditors for a five-year term. The company also announced its 44th AGM for September 30, 2026.
Genesys International Announces 2026 ESOP Scheme and Auditor Changes
- 30,00,000 stock options introduced under 2026 ESOP scheme.
- 1,82,640 additional options adjusted for 2022 scheme holders.
Reader Takeaway: New equity incentives and refreshed auditor oversight signal long-term management continuity and employee retention strategy.
What just happened
Genesys International Corporation Ltd has formalized its "Genesys ESOP Scheme – 2026," authorizing the grant of up to 30 lakh stock options to employees across the company and its subsidiaries. Each option is convertible into one equity share with a ₹5 face value. Simultaneously, the board adjusted the 2022 ESOP scheme, granting 1,82,640 additional options at an exercise price of ₹50 following the company's recent rights issue.
Corporate Governance Changes
In a significant shift for financial oversight, the company appointed M/s. G. K. Choksi & Co. as Statutory Auditors for a five-year term starting from the conclusion of the upcoming 44th AGM. They replace the outgoing firm, M/s. MSKA & Associates. Additionally, the firm named M/s. XAG & Co. as the new Internal Auditor, succeeding the outgoing H.C. Vora & Associates.
AGM Details
The Board of Directors has finalized the notice for the 44th Annual General Meeting. The meeting is set to take place on September 30, 2026, at 3:30 PM via video conferencing and other audio-visual means.
What to track next
Investors should monitor the specific performance milestones attached to the new 30 lakh ESOP pool and the impact of these changes on the company’s administrative structure as it enters the next five-year auditor term.